The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Roles of flavonoids against coronavirus infection
Open accessAbstract
In terms of public health, the 21st century has been characterized by coronavirus pandemics: in 2002-03 the virus SARS-CoV caused SARS; in 2012 MERS-CoV emerged and in 2019 a new human betacoronavirus strain, called SARS-CoV-2, caused the unprecedented COVID-19 outbreak. During the course of the current epidemic, medical challenges to save lives and scientific research aimed to reveal the genetic evolution and the biochemistry of the vital cycle of the new pathogen could lead to new preventive and therapeutic strategies against SARS-CoV-2. Up to now, there is no cure for COVID-19 and waiting for an efficacious vaccine, the development of “savage” protocols, based on “old” anti-inflammatory and anti-viral drugs represents a valid and alternative therapeutic approach. As an alternative or additional therapeutic/preventive option, different in silico and in vitro studies demonstrated that small natural molecules, belonging to polyphenol family, can interfere with various stages of coronavirus entry and replication cycle. Here, we reviewed the capacity of well-known (e.g. quercetin, baicalin, luteolin, hesperetin, gallocatechin gallate, epigallocatechin gallate) and uncommon (e.g. scutellarein, amentoflavone, papyriflavonol A) flavonoids, secondary metabolites widely present in plant tissues with antioxidant and anti-microbial functions, to inhibit key proteins involved in coronavirus infective cycle, such as PLpro, 3CLpro, NTPase/helicase. Due to their pleiotropic activities and lack of systemic toxicity, flavonoids and their derivative may represent target compounds to be tested in future clinical trials to enrich the drug arsenal against coronavirus infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses, Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0695-z · Cited by 8,403
Endothelial cell infection and endotheliitis in COVID-19
Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A. S., Mehra, M. R., Schuepbach, R. A., Ruschitzka, F., & Moch, H. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30937-5 · Cited by 6,358
Origin and evolution of pathogenic coronaviruses
Cui, J., Li, F., & Shi, Z.-L. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0118-9 · Cited by 5,515
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Yan, R., Zhang, Y., Li, Y., Xia, L., Guo, Y., & Zhou, Q. (2020) · Science · doi:10.1126/science.abb2762 · Cited by 5,040
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2223-y · Cited by 4,358
Structural basis of receptor recognition by SARS-CoV-2
Shang, J., Ye, G., Shi, K., Wan, Y., Luo, C., Aihara, H., Geng, Q., Auerbach, A., & Li, F. (2020) · Nature · doi:10.1038/s41586-020-2179-y · Cited by 3,661 · cited 2×
“Finally, Phe486, present in the RBM of SARS-CoV-2, is inserted into a hydrophobic pocket of N-terminal α 1 helix of ACE2, while a leucine residue present in RBM of SARS-CoV forms probably a weaker contact owing to its smaller chain [32].”
Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020) · Science · doi:10.1126/science.abb3405 · Cited by 2,895
Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China
Wu, A., Peng, Y., Huang, B., Ding, X., Wang, X., Niu, P., Meng, J., Zhu, Z., Zhang, Z., Wang, J., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.02.001 · Cited by 2,361
A Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,009
Hoffmann, M., Kleine-Weber, H., & Pöhlmann, S. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.04.022 · Cited by 1,852 · cited 2×
“Hoffman et al. (2020) recently demonstrated that the life cycle of SARS-CoV-2 begins with the RBD of the S protein that makes contact with the ACE2 receptor on the host cells [27,28].”
BackgroundMultiorgan and Renal Tropism of SARS-CoV-2
Puelles, V. G., Lütgehetmann, M., Lindenmeyer, M. T., Sperhake, J. P., Wong, M. N., Allweiss, L., Chilla, S., Heinemann, A., Wanner, N., Liu, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2011400 · Cited by 1,775 · cited 1×
“Here, SARS-CoV-2 can target different tissues at multiple levels, starting from the cells of nose and throat down to the lung, invading, perhaps, through vasal endothelium, kidneys and nervous system where it can cause severe illness and death [4,5].”
BackgroundCoronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS Drugs
Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R., & Hilgenfeld, R. (2003) · Science · doi:10.1126/science.1085658 · Cited by 1,728
Zhong, N., Zheng, B., Li, Y., Poon, L., Xie, Z., Chan, K., Li, P., Tan, S., Chang, Q., Xie, J., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14630-2 · Cited by 1,579
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Dai, W., Zhang, B., Jiang, X.-M., Su, H., Li, J., Zhao, Y., Xie, X., Jin, Z., Peng, J., Liu, F., et al. (2020) · Science · doi:10.1126/science.abb4489 · Cited by 1,478
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Goldman, J. D., Lye, D. C. B., Hui, D. S., Marks, K. M., Bruno, R., Montejano, R., Spinner, C. D., Galli, M., Ahn, M.-Y., Nahass, R. G., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2015301 · Cited by 1,362
de Groot, R. J., Baker, S. C., Baric, R. S., Brown, C. S., Drosten, C., Enjuanes, L., Fouchier, R. A. M., Galiano, M., Gorbalenya, A. E., Memish, Z. A., et al. (2013) · Journal of Virology · doi:10.1128/jvi.01244-13 · Cited by 1,236
Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
Yin, W., Mao, C., Luan, X., Shen, D.-D., Shen, Q., Su, H., Wang, X., Zhou, F., Zhao, W., Gao, M., et al. (2020) · Science · doi:10.1126/science.abc1560 · Cited by 1,219 · cited 1×
“…EIDD-2801, showed more potent effects than Remdesivir in blocking virus replication for the capacity to form two extra hydrogen bonds with the key residue Lys545 within the catalytic domain of replicase and N4 hydroxyl group off the cytidine ring, and a guanine base in the template strand [35].”
BackgroundFlavonoids as Important Molecules of Plant Interactions with the Environment
Mierziak, J., Kostyn, K., & Kulma, A. (2014) · Molecules · doi:10.3390/molecules191016240 · Cited by 1,197
Human Coronavirus: Host-Pathogen Interaction
Fung, T. S., & Liu, D. X. (2019) · Annual Review of Microbiology · doi:10.1146/annurev-micro-020518-115759 · Cited by 960
Structure and function of enzymes involved in the biosynthesis of phenylpropanoids
Ferrer, J.-L., Austin, M. B., Stewart, C., & Noel, J. P. (2008) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2007.12.009 · Cited by 873
Iddir, M., Brito, A., Dingeo, G., Fernandez Del Campo, S. S., Samouda, H., La Frano, M. R., & Bohn, T. (2020) · Nutrients · doi:10.3390/nu12061562 · Cited by 786
Traditional Chinese medicine for COVID-19 treatment
Ren, J.-L., Zhang, A.-H., & Wang, X.-J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104743 · Cited by 693
Inhibition of SARS-CoV 3CL protease by flavonoids
Jo, S., Kim, S., Shin, D. H., & Kim, M.-S. (2020) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2019.1690480 · Cited by 685
Flavonoid biosynthetic pathways in plants: Versatile targets for metabolic engineering
Nabavi, S. M., Šamec, D., Tomczyk, M., Milella, L., Russo, D., Habtemariam, S., Suntar, I., Rastrelli, L., Daglia, M., Xiao, J., et al. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.005 · Cited by 664
Rodriguez-Mateos, A., Vauzour, D., Krueger, C. G., Shanmuganayagam, D., Reed, J., Calani, L., Mena, P., Del Rio, D., & Crozier, A. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1330-7 · Cited by 602
Human Coronaviruses: A Review of Virus–Host Interactions
Lim, Y., Ng, Y., Tam, J., & Liu, D. (2016) · Diseases · doi:10.3390/diseases4030026 · Cited by 591
Anti‐infective properties of epigallocatechin‐3‐gallate (EGCG), a component of green tea
Steinmann, J., Buer, J., Pietschmann, T., & Steinmann, E. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12009 · Cited by 559
SARS — beginning to understand a new virus
Stadler, K., Masignani, V., Eickmann, M., Becker, S., Abrignani, S., Klenk, H.-D., & Rappuoli, R. (2003) · Nature Reviews Microbiology · doi:10.1038/nrmicro775 · Cited by 557
Antiviral effect of flavonoids on human viruses
Kaul, T. N., Middleton, E., & Ogra, P. L. (1985) · Journal of Medical Virology · doi:10.1002/jmv.1890150110 · Cited by 557
Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition
Ryu, Y. B., Jeong, H. J., Kim, J. H., Kim, Y. M., Park, J.-Y., Kim, D., Naguyen, T. T. H., Park, S.-J., Chang, J. S., Park, K. H., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.09.035 · Cited by 546
In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds
Chen, F., Chan, K. H., Jiang, Y., Kao, R. Y. T., Lu, H. T., Fan, K. W., Cheng, V. C. C., Tsui, W. H. W., Hung, I. F. N., & Lee, T. S. W. (2004) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.03.003 · Cited by 534
COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation
Zabetakis, I., Lordan, R., Norton, C., & Tsoupras, A. (2020) · Nutrients · doi:10.3390/nu12051466 · Cited by 532
Wang, J. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00179 · Cited by 498
Small Molecules Blocking the Entry of Severe Acute Respiratory Syndrome Coronavirus into Host Cells
Yi, L., Li, Z., Yuan, K., Qu, X., Chen, J., Wang, G., Zhang, H., Luo, H., Zhu, L., Jiang, P., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.11334-11339.2004 · Cited by 485
Harcourt, B. H., Jukneliene, D., Kanjanahaluethai, A., Bechill, J., Severson, K. M., Smith, C. M., Rota, P. A., & Baker, S. C. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13600-13612.2004 · Cited by 462
Anti-inflammatory Effects of Flavonoids in Neurodegenerative Disorders
Spagnuolo, C., Moccia, S., & Russo, G. L. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.09.001 · Cited by 458
Self-citationNatural product-derived phytochemicals as potential agents against coronaviruses: A review
Mani, J. S., Johnson, J. B., Steel, J. C., Broszczak, D. A., Neilsen, P. M., Walsh, K. B., & Naiker, M. (2020) · Virus Research · doi:10.1016/j.virusres.2020.197989 · Cited by 450
Yu, M.-S., Lee, J., Lee, J. M., Kim, Y., Chin, Y.-W., Jee, J.-G., Keum, Y.-S., & Jeong, Y.-J. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.04.081 · Cited by 422
Ziebuhr, J. (2005) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-26765-4_3 · Cited by 393
Joshi, R. S., Jagdale, S. S., Bansode, S. B., Shankar, S. S., Tellis, M. B., Pandya, V. K., Chugh, A., Giri, A. P., & Kulkarni, M. J. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1760137 · Cited by 354
Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris
Nguyen, T. T. H., Woo, H.-J., Kang, H.-K., Nguyen, V. D., Kim, Y.-M., Kim, D.-W., Ahn, S.-A., Xia, Y., & Kim, D. (2012) · Biotechnology Letters · doi:10.1007/s10529-011-0845-8 · Cited by 347
Rapid repurposing of drugs for COVID-19
Guy, R. K., DiPaola, R. S., Romanelli, F., & Dutch, R. E. (2020) · Science · doi:10.1126/science.abb9332 · Cited by 304
The potential chemical structure of anti‐SARS‐CoV‐2 RNA‐dependent RNA polymerase
Lung, J., Lin, Y., Yang, Y., Chou, Y., Shu, L., Cheng, Y., Liu, H. T., & Wu, C. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25761 · Cited by 295
Yu, R., Chen, L., Lan, R., Shen, R., & Li, P. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106012 · Cited by 290
Chen, L., Li, J., Luo, C., Liu, H., Xu, W., Chen, G., Liew, O. W., Zhu, W., Puah, C. M., Shen, X., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.09.014 · Cited by 265
Characteristics of flavonoids as potent MERS‐CoV 3C‐like protease inhibitors
Jo, S., Kim, H., Kim, S., Shin, D. H., & Kim, M. (2019) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13604 · Cited by 242
Cho, J. K., Curtis-Long, M. J., Lee, K. H., Kim, D. W., Ryu, H. W., Yuk, H. J., & Park, K. H. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.03.027 · Cited by 236
Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV
Park, J.-Y., Ko, J.-A., Kim, D. W., Kim, Y. M., Kwon, H.-J., Jeong, H. J., Kim, C. Y., Park, K. H., Lee, W. S., & Ryu, Y. B. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2014.1003215 · Cited by 231
Antiviral activity of quercetin 7-rhamnoside against porcine epidemic diarrhea virus
Choi, H.-J., Kim, J.-H., Lee, C.-H., Ahn, Y.-J., Song, J.-H., Baek, S.-H., & Kwon, D.-H. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2008.10.002 · Cited by 225
Phytochemicals in Cancer Prevention and Therapy: Truth or Dare?
Russo, M., Spagnuolo, C., Tedesco, I., & Russo, G. L. (2010) · Toxins · doi:10.3390/toxins2040517 · Cited by 225
Self-citationYang, R., Liu, H., Bai, C., Wang, Y., Zhang, X., Guo, R., Wu, S., Wang, J., Leung, E., Chang, H., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104820 · Cited by 217
Sargiacomo, C., Sotgia, F., & Lisanti, M. P. (2020) · Aging · doi:10.18632/aging.103001 · Cited by 213
Kim, D. W., Seo, K. H., Curtis-Long, M. J., Oh, K. Y., Oh, J.-W., Cho, J. K., Lee, K. H., & Park, K. H. (2014) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2012.753591 · Cited by 208
Dexamethasone in the management of covid -19
Johnson, R. M., & Vinetz, J. M. (2020) · BMJ · doi:10.1136/bmj.m2648 · Cited by 200
Can ethnopharmacology contribute to the development of antiviral drugs?
Vlietinck, A. J., & Vanden Berghe, D. A. (1991) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(91)90112-q · Cited by 190
Rahman, N., Basharat, Z., Yousuf, M., Castaldo, G., Rastrelli, L., & Khan, H. (2020) · Molecules · doi:10.3390/molecules25102271 · Cited by 183
Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein
Pillay, T. S. (2020) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2020-206658 · Cited by 172
Functional Role of Dietary Intervention to Improve the Outcome of COVID-19: A Hypothesis of Work
Messina, G., Polito, R., Monda, V., Cipolloni, L., Di Nunno, N., Di Mizio, G., Murabito, P., Carotenuto, M., Messina, A., Pisanelli, D., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093104 · Cited by 171
Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection
Zhuang, M., Jiang, H., Suzuki, Y., Li, X., Xiao, P., Tanaka, T., Ling, H., Yang, B., Saitoh, H., Zhang, L., et al. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.02.001 · Cited by 168
Antioxidant polyphenols in cancer treatment: Friend, foe or foil?
Russo, G. L., Tedesco, I., Spagnuolo, C., & Russo, M. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.05.005 · Cited by 154
Self-citationMagro, G. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198070 · Cited by 139
Effects of propolis flavonoids on virus infectivity and replication.
Debiaggi, M., Tateo, F., Pagani, L., Luini, M. V., & Romero, E. (1990) · PubMed · Cited by 119
Kapikian, A. Z., James, H. D., Kelly, S. J., Dees, J. H., Turner, H. C., McIntosh, K., Kim, H., Parrott, R. H., Vincent, M. M., & Chanock, R. M. (1969) · The Journal of Infectious Diseases · doi:10.1093/infdis/119.3.282 · Cited by 102
Isotope dilution tandem mass spectrometric method for T4/T3
Soukhova, N. V., Soldin, O. P., & Soldin, S. J. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.01.007 · Cited by 96
Apigenin Restricts FMDV Infection and Inhibits Viral IRES Driven Translational Activity
Qian, S., Fan, W., Qian, P., et al. (2015) · Viruses · doi:10.3390/v7041613 · Cited by 95
Clark, K., Grant, P. G., Sarr, A. B., Belakere, J. R., Swaggerty, C. L., Phillips, T. D., & Woode, G. N. (1998) · Veterinary Microbiology · doi:10.1016/s0378-1135(98)00242-9 · Cited by 91
Roh, C. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s31379 · Cited by 91
Development of chemical inhibitors of the SARS coronavirus: Viral helicase as a potential target
Keum, Y., & Jeong, Y. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.08.012 · Cited by 86
Haslberger, A. G., Jacob, U., Hippe, B., & Karlic, H. (2020) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v10i5.707 · Cited by 71
Dubey, K., & Dubey, R. (2020) · Biomedical Journal · doi:10.1016/j.bj.2020.05.002 · Cited by 50
Cited by
Gu, Y.-Y., Zhang, M., Cen, H., Wu, Y.-F., Lu, Z., Lu, F., Liu, X.-S., & Lan, H.-Y. (2021) · PLOS ONE · doi:10.1371/journal.pone.0245209 · Cited by 75
The Interaction of Viruses with the Cellular Senescence Response
Seoane, R., Vidal, S., Bouzaher, Y. H., El Motiam, A., & Rivas, C. (2020) · Biology · doi:10.3390/biology9120455 · Cited by 49
From Sea to Skin: Is There a Future for Natural Photoprotectants?
Milito, A., Castellano, I., & Damiani, E. (2021) · Marine Drugs · doi:10.3390/md19070379 · Cited by 43
“They have also recently been proposed as an alternative co-adjuvant therapy against coronavirus infections, or in combination with classical antiviral drugs [104].”
BackgroundParisi, G. F., Carota, G., Castruccio Castracani, C., Spampinato, M., Manti, S., Papale, M., Di Rosa, M., Barbagallo, I., & Leonardi, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052465 · Cited by 43
Metadata
- Authors
- Russo, M., Moccia, S., Spagnuolo, C., Tedesco, I., & Russo, G. L.
- Venue
- Chemico-Biological Interactions
- Publisher
- Elsevier BV
- Published
- 2020-09
- Volume
- 328
- Pages
- 109211
- ISSN
- 0009-2797 (ISSN-L)
- OpenAlex
- W3045668730
- Cited by
- 323
- References
- 73
- FWCI
- 32.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.